Rule 8.1 and 8.2 (OPD)

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1. KEY INFORMATION

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(c) Irrevocable commitments and letters of intent

* 59,024,389 Synergy shares currently in issue

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

3.1 STERIS DIRECTORS

3.2 STERIS DIRECTORS' STOCK OPTIONS AND UNITS

(A) OPTION TO PURCHASE COMMON SHARES

(B) CAREER RESTRICTED STOCK UNITS

3.3 THE STERIS CORPORATION 401(k) PLAN

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

(b) Agreements, arrangements or understandings relating to options or derivatives

(c) Attachments

Are any Supplemental Forms attached?

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

[1] These amounts include common shares of STERIS Corporation held by the directors both directly and indirectly. In some cases the shares are held in trusts, as disclosed in Securities and Exchange Commission filings.

2 These amounts include common shares of STERIS Corporation held by the directors both directly and indirectly. In some cases the shares are held in trusts, as disclosed.

3 STERIS Non-Qualified Stock Options, including both vested and unvested options. When vested the holder is entitled to purchase one share of STERIS common stock at a price per share equal to the closing market price of STERIS corporation on the grant date. Information containing full details of the directors options are set out on the website at www.steris.com/synergy.

4 The number of CRSUs a director is entitled to receive for each annual term will be determined based upon the dollar amount of the retainer fees elected to be received in CRSUs and the STERIS per share closing price on the NYSE on a specified date at the beginning of the annual term. A director's CRSUs will be settled in STERIS common shares six months after the cessation of the director's board service.

5 The STERIS Corporation 401(k) Plan includes a STERIS Stock Fund. Each participant in the STERIS Stock Fund holds a certain number of STERIS Stock Units that are the equivalent of a certain number of STERIS common shares. As of 7 October 2014, the STERIS Stock Fund held in total 704,215.590 units which were the equivalent of 686,948 STERIS common shares. With regards to voting at the Annual Meeting of Shareholders, Vanguard Fiduciary Trust Company, acts as trustee under the STERIS Corporation 401(k) Plan and Trust. All common shares of STERIS Corporation held under the Plan for which the trustee does not receive a direction from a participant in the plan will be voted by the trustee in the same proportion as it votes those shares with respect to which it does receive voting instructions.

Additional Information

This document is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there by any sale, issuance, exchange or transfer of the securities referred to in this document to any jurisdiction in contravention of applicable law. Subject to future developments, STERIS may file a registration statement and/or tender offer documents with the SEC in connection with a combination. Holders of Synergy Health and/or STERIS shares should read those filings, and any other filings made by STERIS with the SEC in connection with the combination, as they will contain important information. Those documents, if and when filed, as well as STERIS's other public filings with the SEC may be obtained without charge at the SEC's website at www.sec.gov and at STERIS's website at www.STERIS.com/about/ir/sec.cfm.